Anti-CD20 Antibody (Divozilimab)
Catalog No.
F1160
Anti-CD20 Antibody (Divozilimab)
Featured Products
Divozilimab (BCD-132) is a humanized monoclonal antibody against CD20 (CD20). Divozilimab is used in multiple sclerosis research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.26 kDa
Dry ice
2254061-60-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BCD 132, BCD-132
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P11836
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized Human CD20 VLP at 5 ug/mL (30 ul/well) can bind Anti-CD20 Antibody (Divozilimab), The EC50 was approximately 0.01698 ug/ml.
CD20
Please avoid freeze-thaw cycles.